Proteomics International Laboratories Ltd Stock OTC Markets
Stocks
PIQLF
AU000000PIQ0
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2600 USD | -16.13% |
|
-.--% | - |
| 04-16 | Proteomics International Laboratories says restructure, executive appointment and board update | RE |
| 04-16 | Proteomics International Laboratories Ltd Announces Organizational Restructure | CI |
| Market Cap | 19M 13.18M 11.54M 10.63M 9.87M 18.74M 1.26B 127M 49.54M 617M 49.5M 48.42M 2.14B | P/E 2024 |
-17.4x | P/E 2025 | -5.38x |
|---|---|---|---|---|---|
| Enterprise Value | 8.24M 5.72M 5.01M 4.61M 4.28M 8.13M 545M 55.19M 21.48M 268M 21.47M 20.99M 928M | EV / Sales 2024 |
33.2x | EV / Sales 2025 | 12.8x |
| Free-Float |
74.46% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -16.13% |
| 1 year | 0.26 |  | 0.26 |
| 3 years | 0.26 | | 0.31 |
| 5 years | 0.26 | | 0.31 |
| 10 years | 0.26 | | 0.31 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Morris
CEO | Chief Executive Officer | - | 2026-01-18 |
Tim Luscombe
DFI | Director of Finance/CFO | - | 2026-04-16 |
Jacqueline Gray
DFI | Director of Finance/CFO | - | 2021-07-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul House
BRD | Director/Board Member | - | 2017-11-21 |
Williams James
CHM | Chairman | 56 | - |
Aaron Brinkworth
BRD | Director/Board Member | - | 2024-11-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -16.13% | -.--% | - | - | 22.91M | |
| -2.14% | +3.51% | +74.50% | +131.10% | 59.1B | |
| -0.93% | +4.05% | +73.64% | +90.53% | 55.19B | |
| -3.04% | +0.69% | -13.76% | -10.26% | 24.67B | |
| +0.54% | +7.17% | +15.78% | +454.87% | 24.19B | |
| +0.64% | +14.41% | +44.27% | -3.20% | 19.69B | |
| -2.19% | +6.34% | +39.72% | -29.60% | 17.56B | |
| +3.58% | +25.11% | +196.41% | +363.46% | 16.22B | |
| +4.91% | +25.24% | +44.61% | - | 14.84B | |
| -1.03% | +1.84% | +25.18% | +185.98% | 14.04B | |
| Average | -1.58% | +8.39% | +55.60% | +147.86% | 27.28B | |
| Weighted average by Cap. | -0.61% | +6.43% | +58.17% | +136.21% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.28M 2.27M 1.99M 1.83M 1.7M 3.23M 217M 21.95M 8.54M 106M 8.54M 8.35M 369M | 3.31M 2.3M 2.01M 1.85M 1.72M 3.27M 219M 22.19M 8.64M 108M 8.63M 8.44M 373M |
| Net income | -6.38M -4.42M -3.88M -3.57M -3.31M -6.29M -422M -42.72M -16.63M -207M -16.62M -16.25M -718M | -8.11M -5.63M -4.93M -4.54M -4.22M -8.01M -537M -54.37M -21.16M -264M -21.15M -20.68M -914M |
| Net Debt | -6.32M -4.39M -3.84M -3.54M -3.29M -6.24M -419M -42.37M -16.49M -205M -16.48M -16.12M -712M | -10.76M -7.47M -6.54M -6.02M -5.59M -10.62M -712M -72.09M -28.06M -350M -28.04M -27.42M -1.21B |
Employees
-
Annual profits - Rate of surprise
- Stock Market
- Stocks
- PIQ Stock
- PIQLF Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
